Observed Signal · Oct 30, 2026 · earnings · Source: SEC API · Impact: 3.7/5
10-Q Financial Filing Analysis for Colgate-Palmolive (2026-10-30)
Colgate-Palmolive reported solid Q3 2026 financial results, with net sales increasing 4.6% year-over-year to $5,369 million, driven by 1.7% volume growth, 2.0% pricing gains, and a 1.0% foreign exchange tailwind. Organic sales grew 3.6%, bolstered by strength in Latin America (+6.0%) and Hill's Pet Nutrition (+5.7%), offsetting a 1.6% organic sales decline in North America. Operating profit rose 2.7% to $1,088 million, while diluted EPS increased to $0.94 ($0.97 non-GAAP), supported by gross margin expansion of 80 bps to 60.2% through funding-the-growth cost savings. Operating performance absorbed $30 million of pre-tax restructuring charges in Q3 ($333 million year-to-date) associated with the Strategic Growth and Productivity Program, which targets $200–$300 million in annualized pre-tax savings by 2028. Free cash flow generation remained strong, with nine-month operating cash flows increasing 6.1% to $2,913 million. Despite continued raw material inflation and macroeconomic softness, the company sustained market leadership, maintaining a 41.4% global toothpaste market share.
Demonstrates resilience in consumer staples via gross margin expansion (60.2%) and organic growth despite North American volume contraction, while execution of the global restructuring program drives supply chain efficiencies.
Track Colgate-Palmolive Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Net sales in Q3 2026 reached $5,369 million (+4.6% YoY) with organic sales growth of 3.6%, while GAAP net income attributable to the company rose to $751 million ($0.94 diluted EPS; $0.97 non-GAAP diluted EPS).
- Operating cash flow reached $2,913 million for the first nine months of 2026 compared to $2,745 million in 2025, funding $1,308 million in dividends and $927 million in treasury share repurchases.
- Cumulative pre-tax restructuring charges under the Strategic Growth and Productivity Program reached $346 million as of September 30, 2026, out of an estimated total of $350 to $550 million expected by December 31, 2028.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
10-Q Financial Filing Analysis for Church & Dwight (2026-10-30)
Church & Dwight Co., Inc. reported third-quarter 2026 financial results showing modest top-line expansion alongside notable margin improvement. Net sales grew 1.0% year-over-year to $1,602.1 million, driven by a 4.6% increase in product volumes and a 1.9% contribution from acquisitions, partially offset by a 6.1% drag from product line exits completed in 2025 (including VMS, Flawless, and Spinbrush). Gross margin expanded 170 basis points to 46.8%, benefiting from productivity initiatives, portfolio mix improvements, and $17.1 million in tariff refunds under the International Emergency Economic Powers Act (IEEPA). Operating income advanced 14.5% to $291.4 million, pushing operating margin up 210 basis points to 18.2%. Diluted earnings per share increased 18.7% to $0.89. Year-to-date operating cash flow totaled $841.2 million. In capital allocation, the Board of Directors authorized a new $1,000.0 million share repurchase program on October 27, 2026, replacing the 2021 authorization, while capital expenditures are projected at approximately $125.0 million for the full year.
10-Q Financial Filing Analysis for PepsiCo (2026-10-08)
PepsiCo reported solid financial performance for the third quarter (12 weeks ended September 5, 2026), with net revenue rising 6% year-over-year to $25.27 billion and operating profit growing 19% to $4.26 billion. Growth was supported by effective net pricing, productivity gains under the multi-year cost program, and a favorable comparison against prior-year impairment charges, despite flat organic revenue growth in PepsiCo Foods North America (PFNA). Diluted EPS reached $2.23 compared to $1.90 in the prior-year period. For the 36-week period, net cash provided by operating activities increased substantially to $7.95 billion, generating $5.86 billion in free cash flow. PepsiCo maintained active capital return initiatives, repurchasing shares and declaring dividends while updating fair value estimates on strategic holdings, including Celsius and the poppi acquisition contingent consideration.
10-Q Financial Filing Analysis for P&G (2026-10-22)
For the first fiscal quarter ended September 30, 2026, The Procter & Gamble Company reported consolidated net sales of $23.28 billion, up 4.0% year-over-year, driven by a 2.4% unit volume increase, 1.1% positive geographic mix, and 0.4% higher pricing. Operating income rose 1.4% to $5.94 billion, while gross margin contracted 160 basis points to 49.8% due to higher commodity costs and product/packaging investments, partially offset by manufacturing productivity gains. Net earnings attributable to P&G declined marginally to $4.73 billion, while diluted EPS increased 1% to $1.97 (Core EPS rose 1% to $2.00). Operating cash flow reached $5.77 billion with free cash flow of $4.40 billion, demonstrating solid 93% free cash flow productivity. Subsequent to quarter-end on October 1, 2026, P&G completed the $3.9 billion all-cash acquisition of premium wellness brand Thorne. The company also progressed its two-year $2.0 billion portfolio and productivity restructuring plan, which aims to reduce up to 7,000 non-manufacturing personnel by the end of fiscal 2027.
Receive all future signals for Colgate-Palmolive & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.